(NASDAQ: LNTH) Lantheus Holdings's forecast annual revenue growth rate of 4.17% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.84%.
Lantheus Holdings's revenue in 2025 is $1,520,653,000.On average, 5 Wall Street analysts forecast LNTH's revenue for 2025 to be $100,447,756,318, with the lowest LNTH revenue forecast at $99,387,047,593, and the highest LNTH revenue forecast at $101,290,883,765. On average, 6 Wall Street analysts forecast LNTH's revenue for 2026 to be $106,681,187,921, with the lowest LNTH revenue forecast at $96,075,732,537, and the highest LNTH revenue forecast at $115,012,103,034.
In 2027, LNTH is forecast to generate $117,644,156,541 in revenue, with the lowest revenue forecast at $104,717,788,875 and the highest revenue forecast at $124,592,478,628.